CD300a/c regulate type i interferon and TNF-α secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands

Blood

Volumn 112, Issue 4, 2008, Pages 1184-1194

  Ju, Xinsheng ^a   Zenke, Martin ^b,c   Hart, Derek N J ^a   Clark, Georgina J ^a  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD300A ANTIGEN; CD300C ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD300A PROTEIN, HUMAN; CD300C PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; INTERFERON; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA; TLR7 PROTEIN, HUMAN;

ARTICLE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME REGULATION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DOWN REGULATION; DRUG POTENTIATION; GENE EXPRESSION PROFILING; GENETICS; PHYSIOLOGY; SECRETION;

ANTIGENS, CD; ANTIGENS, SURFACE; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE I; LIGANDS; MEMBRANE GLYCOPROTEINS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR-ALPHA;

EID: 51649099812     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-12-127951     Document Type: Article

References (50)

1. Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419-426.
2. Colonna M. Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol. 2004;5:1219-1226.
3. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 1997;90:3245-3287.
4. Kawai T Akira S. Innate immune recognition of viral infection. Nat Immunol. 2006;7:131-137.
5. Liu YJ, KanzlerH, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001 ;2:585-589.
6. Farkas L. Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001 ;159:237-243.
7. Bave U, Nordmark G, Lovgren T, et al. Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum. 2005;52:1185-1195.
8. Gottenberg JE, Cagnard N, Lucchesi C, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci USA. 2006;103:2770-2775.
9. Gilliet M, Conrad C, Geiges M, et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 2004;140:1490-1495.
10. Lande R, Giacomini E, Serafini B. et al. Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol. 2004;173:2815-2824.
11. Toukap AN, Galant C, Theate I, et al. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 2007;56:1579-1588.
12. Nestle FO, Conrad C, Tun-Kyi A, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 2005;202:135-143.
13. Wei S, Kryczek I, Zou L, et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res. 2005;65:5020-5026.
14. Treilleux I, Blay JY, Bendriss-Vermare N, et al. Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res. 2004;10:7466-7474.
15. Fugier-Vivier IJ, Rezzoug F, Huang Y, et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med. 2005;201:373-383.
16. DzionekA, SohmaY. Nagafune J, et al. BDCA-2. a novel plasmacytoid dendritic cell-specific type 11 C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001 ;194:1823-1834.
17. Schroeder JT, BienemanAP. Xiao H, et al. TLR9-and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol. 2005;175:5724-5731.
18. Ju XS, Hacker C, SchererB, et al. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. Gene. 2004;331:159-164.
19. Cao W, Rosen DB, ItoT, et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006;203:1399-1405.
20. Fuchs A, CellaM, Kondo T Colonna M. Paradoxic inhibition of human natural interferon-pro-ducing cells by the activating receptor NKp44. Blood. 2005;106:2076-2082.
21. Blasius AL, CellaM, Maldonado J, Takai T, Colonna M. Siglec-H is an I PC-specific receptor that modulates type I I FN secretion through DAP12. Blood. 2006;107:2474-2476.
22. Zhang J, Raper A, Sugita N, et al. Characteriza tion of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006;107:3600-3608.
23. Clark GJ, Fitzpatrick S, Kuo B, Modra C, Jamriska L, Hart DN. CMRF-35A, CMRF-35H: potential new CD. J Biol Regul Homeost Agents. 2002:16:233-235.
24. Clark GJ, Green BJ, Hart DN. The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17. Tissue Antigens. 2000;55:101 -109.
25. Clark G, Fitzpatrick S, Kuo C, Modra C, Jamriska L, Hart D. The CMRF-35 family of molecules - a new leucocyte receptor complex on chromosome 17. Curr Trends Immunol. 2003;5:55-64.
26. Green BJ, Clark GJ. Hart DN. The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor. Int Immunol. 1998;10:891-899.
27. Daish A, Starling GC, McKenzie JL, Nimmo JC, Jackson DG, Hart DN. Expression of the CMRF-35 antigen, a new member of the immunoglobulin gene superfamily, is differentially regulated on leucocytes. Immunology. 1993;79:55-63.
28. Clark GJ, Rao M, Ju X, Hart DN. Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression. J Leukoc Biol. 2007;82:1126-1135.
29. PaluckaAK, Blanck JP, Bennett L, Pascual V, Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci USA. 2005;102:3372-3377.
30. Kerkmann M, Rothenfusser S, Hornung V, et al. Activation with CpG-Aand CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J Immunol. 2003;170:4465-4474.
31. Summers KL, Hock BD, McKenzie JL, Hart DN. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol. 2001 ;159:285-295.
32. MacDonald KPA, Munster D, Clark GC, Dzionek A, Schmitz J, Hart DNJ. Characterization of human blood dendritic cell subsets. Blood. 2002;100:4512-4520.
33. Hacker C, Kirsch RD, Ju XS, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol. 2003;4:380-386.
34. Ju XS, Zenke M. Gene expression profiling of dendritic cells by DNA microarrays. Immunobiology. 2004;209:155-161.
35. de Mestre AM, Khachigian LM, Santiago FS, Staykova MA, Hulett MD. Regulation of inducible heparanase gene transcription in activated T cells by early growth response 1. J Biol Chem. 2003;278:50377-50385.
36. Osugi Y, Vuckovic S, Hart DN. Myeloid blood CD11c( + ) dendritic cells and rnonocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood. 2002;100:2858-2866.
37. Ito T. Amakawa R. KaishoT, et al. Interferon-al-phaand interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med. 2002;195:1507-1512.
38. Kadowaki N, Antonenko S, Lau JY, Liu YJ. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med. 2000;192:219-226.
39. Kaisho T. Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979-987.
40. Sato M, Suemori H, Hata N, et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000;13:539-548.
41. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25:383-392.
42. Mancuso G, Midiri A, Biondo G. et al. Type I IFN signaling is crucial tor host resistance against different species of pathogenic bacteria. J Immunol. 2007;178:3126-3133.
43. Hoshino K, Sugiyama T, Matsumoto M, et al. IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature. 2006;440:949-953.
44. Osawa Y Iho S, Takauji R, et al. Collaborative action of NF-kappaB and p38 MARK is involved in CpG DNA-induced IFN-alphaand chemokine production in human plasmacytoid dendritic cells. J Immunol. 2006;177:4841-4852.
45. Hornung V, Guenthner-Biller M, Bourquin C, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 2005;11:263-270.
46. Tan JK, Aphale A, Malaviya R, Sun Y Gottlieb AB. Mechanisms of action of etanercept in psoriasis. J Investig Dermatol Symp Proc. 2007;12:38-45.
47. Cantoni C, Bottino C. Augugliaro R, et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol. 1999;29:3148-3159.
48. Bachelet I, Munitz A. Moretta A, Moretta L, Levi- Schaffer F. The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells. J Immunol. 2005;175:7989-7995.
49. Munitz A, Bachelet I, Eliashar R, Moretta A, Moretta L. Levi-Schaffer F. The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophils. Blood. 2006;107:1996-2003.
50. Matte CC. Liu J, Cormier J, et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med. 2004;10:987-992.